Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 10:00AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-22.26 Insider Own0.03% Shs Outstand1.02M Perf Week-5.90%
Market Cap10.24M Forward P/E- EPS next Y-15.26 Insider Trans0.00% Shs Float1.02M Perf Month-17.43%
Income-12.33M PEG- EPS next Q- Inst Own14.75% Short Float0.62% Perf Quarter71.33%
Sales2.24M P/S4.57 EPS this Y67.99% Inst Trans- Short Ratio0.64 Perf Half Y1.97%
Book/sh6.39 P/B1.57 EPS next Y21.12% ROA-128.77% Short Interest0.01M Perf Year-76.99%
Cash/sh5.10 P/C1.97 EPS next 5Y- ROE-198.99% 52W Range5.00 - 45.60 Perf YTD65.95%
Dividend Est.- P/FCF- EPS past 5Y-13.36% ROI-277.71% 52W High-77.98% Beta1.65
Dividend TTM- Quick Ratio2.97 Sales past 5Y-23.13% Gross Margin- 52W Low100.80% ATR (14)0.89
Dividend Ex-Date- Current Ratio2.97 EPS Y/Y TTM68.74% Oper. Margin-538.42% RSI (14)52.92 Volatility8.48% 9.15%
Employees24 Debt/Eq0.08 Sales Y/Y TTM69.39% Profit Margin-550.46% Recom3.50 Target Price21.94
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q56.89% Payout- Rel Volume0.68 Prev Close10.20
Sales Surprise-43.23% EPS Surprise-521.24% Sales Q/Q-13.34% EarningsNov 29 BMO Avg Volume9.79K Price10.04
SMA20-4.49% SMA5021.70% SMA2006.73% Trades Volume1,269 Change-1.57%
Jan-31-24 01:00AM
Jan-09-24 01:00AM
Jan-05-24 01:30AM
Dec-20-23 01:00AM
Dec-14-23 01:00AM
01:21AM Loading…
Nov-29-23 01:21AM
Nov-28-23 01:00AM
Nov-23-23 01:00AM
Nov-14-23 01:00AM
Nov-08-23 01:00AM
Nov-02-23 02:00AM
Oct-20-23 01:00AM
Oct-06-23 04:00PM
Oct-05-23 11:20AM
01:00AM Loading…
Sep-20-23 01:00AM
Sep-06-23 01:00AM
Sep-05-23 01:00AM
Sep-04-23 01:00AM
Aug-10-23 01:00AM
Aug-04-23 01:00AM
Aug-03-23 01:00AM
Jul-24-23 01:00AM
Jun-15-23 01:00AM
Jun-01-23 01:00AM
May-18-23 01:00AM
May-11-23 01:00AM
May-10-23 01:00AM
May-05-23 01:00AM
May-04-23 01:00AM
01:00AM Loading…
Apr-05-23 01:00AM
Apr-04-23 01:00AM
Apr-03-23 01:00AM
Mar-30-23 01:00AM
Mar-28-23 01:00AM
Mar-16-23 02:00AM
Feb-09-23 01:00AM
Feb-06-23 01:00AM
Jan-19-23 01:00AM
Dec-08-22 01:00AM
Nov-11-22 01:00AM
Nov-03-22 02:00AM
Nov-01-22 02:00AM
Sep-20-22 01:00AM
Aug-18-22 01:00AM
Aug-15-22 01:00AM
Aug-12-22 01:00AM
Jul-26-22 04:00PM
Jul-22-22 01:00AM
Jul-21-22 01:00AM
Jun-17-22 01:00AM
May-27-22 01:00AM
May-19-22 01:00AM
May-13-22 01:00AM
May-10-22 01:00AM
May-05-22 01:00AM
Apr-28-22 01:00AM
Apr-25-22 01:00AM
Apr-13-22 01:00AM
Apr-06-22 01:00AM
Mar-31-22 01:00AM
Mar-29-22 12:00PM
Mar-24-22 02:00AM
Mar-10-22 01:10AM
Mar-07-22 01:00AM
Feb-24-22 01:00AM
Feb-15-22 12:00PM
Feb-03-22 01:00AM
Jan-11-22 01:00AM
Jan-06-22 01:00AM
Dec-17-21 01:00AM
Dec-15-21 01:00AM
Nov-18-21 01:00AM
Nov-15-21 01:00AM
Nov-04-21 02:00AM
Nov-01-21 02:00AM
Oct-26-21 03:02PM
Oct-06-21 01:00AM
Oct-04-21 01:00AM
Sep-29-21 01:00AM
Sep-22-21 01:00AM
Sep-08-21 01:00AM
Sep-02-21 01:00AM
Aug-05-21 01:00AM
Aug-02-21 01:00AM
Jul-29-21 01:00AM
Jul-16-21 06:06AM
Jul-08-21 11:20AM
Jul-07-21 01:00AM
Jul-01-21 01:00AM
Jun-30-21 01:00AM
Jun-29-21 01:00AM
Jun-23-21 09:35AM
Jun-17-21 01:00AM
Jun-07-21 01:00AM
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.